CC chemokine ligand
Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
11
Expression of membrane bound CC chemokine ligand 20 on follicular T helper cells in T B cell conjugates
8
The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long term treatment of HTLV 1 associated myelopathy/tropical spastic paraparesis
12
CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection
11
Complementary action of granulocyte macrophage colony stimulating factor and interleukin 17A induces interleukin 23, receptor activator of nuclear factor κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis
14
Therapeutic targets in systemic sclerosis
5
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis related interstitial lung disease
9
Osteoblastogenesis from synovial fluid derived cells is related to the type and severity of juvenile idiopathic arthritis
12
Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells
16
Personalised medicine in interstitial lung diseases
12
Original Article Expression and clinical significance of bFGF and CCL18 in non-small cell lung cancer
8
Ectopic lymphoid neogenesis is strongly associated with activation of the IL 23 pathway in rheumatoid synovitis
12
Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
13
Cloning of the human eosinophil chemoattractant, eotaxin Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils
10
Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti citrullinated peptide/protein antibody positive and –negative rheumatoid arthritis patients
9
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?
8
CCR9 in cancer: oncogenic role and therapeutic targeting
9
Cytomegalovirus CC Chemokine Promotes Immune Cell Migration
12
CXC and CC Chemokine Receptors on Coronary and Brain Endothelia
11
Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
5